Wirostko Barbara 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Sep 15, 2017
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Common Stock
2017-09-14$1.23/sh+9,000$11,070→ 50,700 total(indirect: By Spouse) - Award
Common Stock
2017-09-15$1.20/sh+9,000$10,800→ 228,042 total - Award
Common Stock
2017-09-14$1.22/sh+1,200$1,464→ 219,042 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.19 to $1.21, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.